Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LY2334737

🥰Excellent
Catalog No. T4061Cas No. 892128-60-8

LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.

LY2334737

LY2334737

🥰Excellent
Purity: 99.4%
Catalog No. T4061Cas No. 892128-60-8
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
Pack SizePriceAvailabilityQuantity
1 mg$64In Stock
5 mg$156In Stock
10 mg$239In Stock
25 mg$397In Stock
50 mg$591In Stock
100 mg$818In Stock
1 mL x 10 mM (in DMSO)$169In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "LY2334737"

Select Batch
Purity:99.4%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
In vitro
Five cell lines expressing CES2 responded to LY2334737 treatment, which was less cytotoxic to SK-OV-3 CES2 knockdown than to parental cells. CES2-transfected HCT-116 cell drug response correlated with CES2 expression level. Bystander studies showed significantly greater PC-3-GFP growth inhibition by LY2334737 when cocultured with CES2, not mock transfectants [1].
In vivo
Oral treatment of xenograft models with 3.2 mg/kg LY2334737 once daily for 21 days showed significantly greater tumor growth inhibition in CES2 transfectants compared to mock transfectants (P ≤ 0.001) [1]. The MTD was 40 mg LY2334737. Fatigue was the most frequent DLT for LY2334737 monotherapy (4 patients), followed by elevated transaminase levels (2 patients), both observed at the 40-50 mg dose levels. In the combination arm, 2 of 10 patients experienced DLTs at the 40 mg dose level, which included fatigue and elevated liver enzyme levels [2]. Metronomic LY2334737 administration increased blood flow in luciferase-tagged LM2-4 tumor xenografts, measurable via contrast micro-ultrasound, and coincided with a relative increase in tumor bioluminescence [3].
Chemical Properties
Molecular Weight389.39
FormulaC17H25F2N3O5
Cas No.892128-60-8
SmilesCCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
Relative Density.1.41 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (115.56 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5681 mL12.8406 mL25.6812 mL128.4060 mL
5 mM0.5136 mL2.5681 mL5.1362 mL25.6812 mL
10 mM0.2568 mL1.2841 mL2.5681 mL12.8406 mL
20 mM0.1284 mL0.6420 mL1.2841 mL6.4203 mL
50 mM0.0514 mL0.2568 mL0.5136 mL2.5681 mL
100 mM0.0257 mL0.1284 mL0.2568 mL1.2841 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LY2334737 | purchase LY2334737 | LY2334737 cost | order LY2334737 | LY2334737 chemical structure | LY2334737 in vivo | LY2334737 in vitro | LY2334737 formula | LY2334737 molecular weight